A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia

BACKGROUND: Pentavalent antimonials (Sb5) are the first-line drugs for treating cutaneous leishmaniasis in Colombia; however, given problems with toxicity, compliance, availability, and cost, it is imperative to look for better therapeutic options. Intravenous amphotericin B (AmB) has been used exte...

Descripción completa

Detalles Bibliográficos
Autores principales: López, Liliana, Vélez, Iván, Asela, Claudia, Cruz, Claudia, Alves, Fabiana, Robledo, Sara, Arana, Byron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078324/
https://www.ncbi.nlm.nih.gov/pubmed/30044792
http://dx.doi.org/10.1371/journal.pntd.0006653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078324/
https://www.ncbi.nlm.nih.gov/pubmed/30044792
http://dx.doi.org/10.1371/journal.pntd.0006653

Ejemplares similares